Psychiatric sequelae of phencyclidine abuse.

Area of Science:

• Psychiatry
• Neuroscience
• Pharmacology

Background:

• Phencyclidine (PCP) use is associated with psychosis in a subset of individuals.
• The premorbid personality of those affected by PCP-induced psychosis shares similarities with users of LSD and marijuana who experience prolonged psychiatric issues.
• PCP psychosis often presents with characteristics of a "hallucinogen" psychosis.

Purpose of the Study:

• To differentiate PCP-induced psychosis from other functional psychoses.
• To investigate the unique features of PCP psychosis compared to other psychedelic drug effects.
• To explore the contributing factors to the infrequent occurrence of psychosis despite widespread PCP exposure.

Main Methods:

• Clinical observation and description of PCP-induced psychosis.
• Comparison of clinical features of PCP psychosis with those of LSD and marijuana-induced psychiatric difficulties.
• Analysis of specific characteristics such as neurological abnormalities, dose-dependency, and illness duration.

Main Results:

• PCP psychosis exhibits distinct features, including neurological abnormalities, dose-related symptom severity, and a consistent illness duration, differentiating it from other psychedelic drug psychoses.
• The psychosis induced by PCP shares some phenomenological similarities with "hallucinogen" psychoses.
• Despite a large exposed population, PCP-induced psychosis occurs infrequently.

Conclusions:

• PCP psychosis is primarily considered a direct drug effect rather than a functional psychosis triggered by the drug experience.
• The infrequent occurrence suggests a multifactorial etiology, likely involving a combination of the drug's effects and pre-existing personality vulnerabilities.
• Further research is warranted to fully elucidate the interaction between PCP, personality factors, and psychosis.